Standout Papers

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus... 2003 2026 2010 2018 465
  1. Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413 (2003)
    Mack Roach, Michelle DeSilvio et al. Journal of Clinical Oncology
  2. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer (2018)
    Jeff M. Michalski, Jennifer Moughan et al. JAMA Oncology

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
2021 Standout
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2020 Standout
1 intermediate paper

Works of Michael J. Seider being referenced

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer
2018 Standout
An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation Interactions
2007
and 2 more

Author Peers

Author Last Decade Papers Cites
Michael J. Seider 2003 265 218 1109 421 52 2.9k
James Fletcher 2127 284 266 990 1715 68 4.2k
Ingemar Näslund 1120 577 392 1127 819 69 2.8k
Stephen Davis 773 135 42 945 616 91 2.3k
Zoltán Varga 1141 37 23 220 330 123 2.6k
Bernhard Walter 855 17 27 136 148 47 2.0k
Wolfgang Harms 609 10 25 654 436 109 1.9k
Edward Shaw 2769 20 29 723 805 64 4.7k
Matthew B. Palmer 695 56 5 403 205 58 1.9k
Sharon E. Clarke 411 222 298 58 782 82 2.0k
Michael Andersson 455 36 183 480 400 28 3.4k

All Works

Loading papers...

Rankless by CCL
2026